Aratana Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PETX and buy or sell other stocks, ETFs, and their options commission-free!

About PETX

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. 

CEO
Craig A. Tooman, MBA
CEOCraig A. Tooman, MBA
Employees
—
Employees—
Headquarters
Leawood, Kansas
HeadquartersLeawood, Kansas
Founded
2010
Founded2010
Employees
—
Employees—

PETX Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
—
Average volume—
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$7.16
52 Week high$7.16
52 Week low
$3.30
52 Week low$3.30

Stock Snapshot

Aratana Therapeutics(PETX) stock is priced at $4.92.

Aratana Therapeutics(PETX) stock opened on 2026-02-07 at —. The price climbed to — and dipped to —.

The Aratana Therapeutics(PETX)'s current trading volume is 0.

In the last year, Aratana Therapeutics(PETX) shares hit a 52-week high of $7.16 and a 52-week low of $3.30.

In the last year, Aratana Therapeutics(PETX) shares hit a 52-week high of $7.16 and a 52-week low of $3.30.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.